1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ligand Binding Assay Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Radioactive
1.2.3 Non-radioactive
1.3 Market by Application
1.3.1 Global Ligand Binding Assay Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Biomedical Research
1.3.3 Drug Discovery
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Ligand Binding Assay Market Perspective (2017-2028)
2.2 Ligand Binding Assay Growth Trends by Region
2.2.1 Ligand Binding Assay Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ligand Binding Assay Historic Market Size by Region (2017-2022)
2.2.3 Ligand Binding Assay Forecasted Market Size by Region (2023-2028)
2.3 Ligand Binding Assay Market Dynamics
2.3.1 Ligand Binding Assay Industry Trends
2.3.2 Ligand Binding Assay Market Drivers
2.3.3 Ligand Binding Assay Market Challenges
2.3.4 Ligand Binding Assay Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Ligand Binding Assay Players by Revenue
3.1.1 Global Top Ligand Binding Assay Players by Revenue (2017-2022)
3.1.2 Global Ligand Binding Assay Revenue Market Share by Players (2017-2022)
3.2 Global Ligand Binding Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ligand Binding Assay Revenue
3.4 Global Ligand Binding Assay Market Concentration Ratio
3.4.1 Global Ligand Binding Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ligand Binding Assay Revenue in 2021
3.5 Ligand Binding Assay Key Players Head office and Area Served
3.6 Key Players Ligand Binding Assay Product Solution and Service
3.7 Date of Enter into Ligand Binding Assay Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Ligand Binding Assay Breakdown Data by Type
4.1 Global Ligand Binding Assay Historic Market Size by Type (2017-2022)
4.2 Global Ligand Binding Assay Forecasted Market Size by Type (2023-2028) 5 Ligand Binding Assay Breakdown Data by Application
5.1 Global Ligand Binding Assay Historic Market Size by Application (2017-2022)
5.2 Global Ligand Binding Assay Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Ligand Binding Assay Market Size (2017-2028)
6.2 North America Ligand Binding Assay Market Size by Country (2017-2022)
6.3 North America Ligand Binding Assay Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Ligand Binding Assay Market Size (2017-2028)
7.2 Europe Ligand Binding Assay Market Size by Country (2017-2022)
7.3 Europe Ligand Binding Assay Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Ligand Binding Assay Market Size (2017-2028)
8.2 Asia-Pacific Ligand Binding Assay Market Size by Country (2017-2022)
8.3 Asia-Pacific Ligand Binding Assay Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Ligand Binding Assay Market Size (2017-2028)
9.2 Latin America Ligand Binding Assay Market Size by Country (2017-2022)
9.3 Latin America Ligand Binding Assay Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Ligand Binding Assay Market Size (2017-2028)
10.2 Middle East & Africa Ligand Binding Assay Market Size by Country (2017-2022)
10.3 Middle East & Africa Ligand Binding Assay Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Sygnature Discovery
11.1.1 Sygnature Discovery Company Detail
11.1.2 Sygnature Discovery Business Overview
11.1.3 Sygnature Discovery Ligand Binding Assay Introduction
11.1.4 Sygnature Discovery Revenue in Ligand Binding Assay Business (2017-2022)
11.1.5 Sygnature Discovery Recent Development
11.2 Shanghai Medicilon Inc
11.2.1 Shanghai Medicilon Inc Company Detail
11.2.2 Shanghai Medicilon Inc Business Overview
11.2.3 Shanghai Medicilon Inc Ligand Binding Assay Introduction
11.2.4 Shanghai Medicilon Inc Revenue in Ligand Binding Assay Business (2017-2022)
11.2.5 Shanghai Medicilon Inc Recent Development
11.3 Intertek Group plc
11.3.1 Intertek Group plc Company Detail
11.3.2 Intertek Group plc Business Overview
11.3.3 Intertek Group plc Ligand Binding Assay Introduction
11.3.4 Intertek Group plc Revenue in Ligand Binding Assay Business (2017-2022)
11.3.5 Intertek Group plc Recent Development
11.4 PerkinElmer Inc
11.4.1 PerkinElmer Inc Company Detail
11.4.2 PerkinElmer Inc Business Overview
11.4.3 PerkinElmer Inc Ligand Binding Assay Introduction
11.4.4 PerkinElmer Inc Revenue in Ligand Binding Assay Business (2017-2022)
11.4.5 PerkinElmer Inc Recent Development
11.5 Charles River
11.5.1 Charles River Company Detail
11.5.2 Charles River Business Overview
11.5.3 Charles River Ligand Binding Assay Introduction
11.5.4 Charles River Revenue in Ligand Binding Assay Business (2017-2022)
11.5.5 Charles River Recent Development
11.6 Alliance Pharma
11.6.1 Alliance Pharma Company Detail
11.6.2 Alliance Pharma Business Overview
11.6.3 Alliance Pharma Ligand Binding Assay Introduction
11.6.4 Alliance Pharma Revenue in Ligand Binding Assay Business (2017-2022)
11.6.5 Alliance Pharma Recent Development
11.7 Eurofins Discovery
11.7.1 Eurofins Discovery Company Detail
11.7.2 Eurofins Discovery Business Overview
11.7.3 Eurofins Discovery Ligand Binding Assay Introduction
11.7.4 Eurofins Discovery Revenue in Ligand Binding Assay Business (2017-2022)
11.7.5 Eurofins Discovery Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Detail
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Ligand Binding Assay Introduction
11.8.4 Creative Biogene Revenue in Ligand Binding Assay Business (2017-2022)
11.8.5 Creative Biogene Recent Development
11.9 IBR Inc
11.9.1 IBR Inc Company Detail
11.9.2 IBR Inc Business Overview
11.9.3 IBR Inc Ligand Binding Assay Introduction
11.9.4 IBR Inc Revenue in Ligand Binding Assay Business (2017-2022)
11.9.5 IBR Inc Recent Development
11.10 LGC Limited
11.10.1 LGC Limited Company Detail
11.10.2 LGC Limited Business Overview
11.10.3 LGC Limited Ligand Binding Assay Introduction
11.10.4 LGC Limited Revenue in Ligand Binding Assay Business (2017-2022)
11.10.5 LGC Limited Recent Development
11.11 Accelero Bioanalytics GmbH
11.11.1 Accelero Bioanalytics GmbH Company Detail
11.11.2 Accelero Bioanalytics GmbH Business Overview
11.11.3 Accelero Bioanalytics GmbH Ligand Binding Assay Introduction
11.11.4 Accelero Bioanalytics GmbH Revenue in Ligand Binding Assay Business (2017-2022)
11.11.5 Accelero Bioanalytics GmbH Recent Development
11.12 Gifford Bioscience Limited
11.12.1 Gifford Bioscience Limited Company Detail
11.12.2 Gifford Bioscience Limited Business Overview
11.12.3 Gifford Bioscience Limited Ligand Binding Assay Introduction
11.12.4 Gifford Bioscience Limited Revenue in Ligand Binding Assay Business (2017-2022)
11.12.5 Gifford Bioscience Limited Recent Development
11.13 GE Healthcare
11.13.1 GE Healthcare Company Detail
11.13.2 GE Healthcare Business Overview
11.13.3 GE Healthcare Ligand Binding Assay Introduction
11.13.4 GE Healthcare Revenue in Ligand Binding Assay Business (2017-2022)
11.13.5 GE Healthcare Recent Development
11.14 Antigen Discovery Inc
11.14.1 Antigen Discovery Inc Company Detail
11.14.2 Antigen Discovery Inc Business Overview
11.14.3 Antigen Discovery Inc Ligand Binding Assay Introduction
11.14.4 Antigen Discovery Inc Revenue in Ligand Binding Assay Business (2017-2022)
11.14.5 Antigen Discovery Inc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
